|
Latest News
Meiogen is awarded US Patent #7,285,526
This patent covers the composition of its lead compound Normferon™, its modifications
and its use in the treatment of a diverse range of immunological and neurological diseases.
|
|
|
Normferon™ is expected to be the first,
safest, and most effective interferon
inhibitor available.
 read more
|
|
- Autoimmune Disease
- HIV/AIDS
- Down Syndrome
- Transplant Rejection
|
|
|
|
|
|
|